ICM
LEVI icon

Invenomic Capital Management’s Levi Strauss LEVI Stock Holding History

Invenomic Capital Management’s Portfolio LEVI Stock Details LEVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-807,495
Closed -$13.4M – 172
2023
Q4 		$13.4M Sell
807,495
-595,334
-42% -$8.83M 0.61% 57
2023
Q3 		$19.1M Buy
1,402,829
+208,128
+17% +$2.91M 0.8% 40
2023
Q2 		$17.2M Sell
1,194,701
-100,753
-8% -$1.45M 0.87% 38
2023
Q1 		$23.6M Buy
1,295,454
+32,707
+3% +$562K 1.33% 24
2022
Q4 		$19.6M Buy
1,262,747
+314,942
+33% +$4.89M 1.33% 20
2022
Q3 		$13.7M Buy
947,805
+120,329
+15% +$2.15M 1.18% 29
2022
Q2 		$13.5M Buy
827,476
+312,352
+61% +$5.64M 0.96% 30
2022
Q1 		$8.35M Buy
+515,124
New +$11.1M 0.89% 32

Other funds holding LEVI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
KAH
Kathryn A. Hall $186M AUM 12.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invenomic Capital Management's LEVI Position: Q1 2024 in Review

Invenomic Capital Management sold out of Levi Strauss (LEVI) in Q1 2024, closing a stake of 807,495 shares — an estimated $13.4M sold.

Invenomic Capital Management first reported a position in LEVI in Q1 2022 and held it in 8 quarters. The position peaked at $23.6M in Q1 2023. 197 funds tracked by Wall St. Rank hold LEVI as of Q1 2024.

  • Invenomic Capital Management reported no remaining Levi Strauss position as of Q1 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 807,495 Levi Strauss shares in Q1 2024, an estimated $13.4M.
  • Invenomic Capital Management first reported a position in Levi Strauss in Q1 2022 and held it in 8 quarters.
  • Invenomic Capital Management's Levi Strauss position peaked at $23.6M in Q1 2023.
  • 197 funds tracked by Wall St. Rank held Levi Strauss as of Q1 2024.

Based on Invenomic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.